Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-29 08:22 am Sale |
2023-06-26 | 13G | Avalo Therapeutics, Inc. AVTX |
Caissa Capital Management ltd. | 0 0.000% |
-6,146 (Position Closed) |
Filing History |
| 2023-04-19 4:38 pm Purchase |
2023-04-18 | 13G | Avalo Therapeutics, Inc. AVTX |
Caissa Capital Management ltd. | 6,146 11.190% |
339 (+5.84%) |
Filing History |
| 2023-02-14 4:09 pm Purchase |
2023-02-14 | 13G | Avalo Therapeutics, Inc. AVTX |
Caissa Capital Management ltd. | 5,807 10.570% |
1,721 (+42.13%) |
Filing History |
| 2022-08-08 07:23 am Purchase |
2022-07-25 | 13G | Avalo Therapeutics, Inc. AVTX |
Caissa Capital Management ltd. | 4,086 10.430% |
1,968 (+92.90%) |
Filing History |
| 2022-05-17 3:45 pm Purchase |
2022-05-04 | 13G | Avalo Therapeutics, Inc. AVTX |
Caissa Capital Management ltd. | 2,118 5.410% |
2,118 (New Position) |
Filing History |